Genprex, Inc.
GNPXNASDAQHealthcare● Active
$0.67
+$0.02(+3.76%)
Market Cap$1094965
P/E Ratio—
52W High$55
52W Low$0.634
Genprex, Inc. (GNPX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GNPX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.64
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
🔥 4-Quarter EPS Beat Streak
GNPX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.59B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.59B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | May 13, 2026 | — | -$0.64 | — | — | — | — |
| ▲ Q1 FY2026 | Mar 30, 2026 | -$13.00 | -$1.15 | +91.2% | — | — | — |
| ▲ Q4 FY2025 | Nov 14, 2025 | -$12.50 | -$5.00 | +60.0% | — | — | — |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$21.00 | -$8.50 | +59.5% | — | — | — |
| ▲ Q2 FY2025 | May 12, 2025 | -$0.82 | -$0.26 | +68.3% | — | — | — |
| ▼ Q2 FY2025 | Apr 7, 2025 | -$0.82 | -$1.15 | -40.2% | $0.00B | — | — |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$1.13 | -$1.23 | -8.8% | — | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026
EPS Actual
-$0.64
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 30, 2026Beat
EPS Actual
-$1.15
EPS Est.
-$13.00
EPS Surpr.
+91.2%
Revenue
—
Q4 FY2025
Nov 14, 2025Beat
EPS Actual
-$5.00
EPS Est.
-$12.50
EPS Surpr.
+60.0%
Revenue
—
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$8.50
EPS Est.
-$21.00
EPS Surpr.
+59.5%
Revenue
—
Q2 FY2025
May 12, 2025Beat
EPS Actual
-$0.26
EPS Est.
-$0.82
EPS Surpr.
+68.3%
Revenue
—
Q2 FY2025
Apr 7, 2025Miss
EPS Actual
-$1.15
EPS Est.
-$0.82
EPS Surpr.
-40.2%
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$1.23
EPS Est.
-$1.13
EPS Surpr.
-8.8%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-13.00 | $-13.00 | $-13.00 | 1 |
| Q3 FY2025 | $-12.50 | $-12.50 | $-12.50 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 13, 2026 | — | $0.83 | $0.85 | +2.54% |
| ▲ Q1 FY2026 | Mar 30, 2026 | +91.2% | $1.82 | $1.77 | -2.75% |
| ▲ Q4 FY2025 | Nov 14, 2025 | +60.0% | $4.14 | $4.43 | +7.00% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +59.5% | $11.26 | $10.80 | -4.09% |
| ▲ Q2 FY2025 | May 12, 2025 | +68.3% | $14.27 | $13.80 | -3.29% |
| ▼ Q2 FY2025 | Apr 7, 2025 | -40.2% | $16.75 | $15.51 | -7.40% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -8.8% | $104.50 | $80.00 | -23.44% |
| ▼ Q3 FY2024 | Aug 9, 2024 | -30.4% | $71.00 | $71.00 | +0.00% |
Q2 FY2026+2.54%
Report Date
May 13, 2026
EPS Beat/Miss
—
Price Before
$0.83
Price After
$0.85
Q1 FY2026-2.75%
Report Date
Mar 30, 2026
EPS Beat/Miss
+91.2%
Price Before
$1.82
Price After
$1.77
Q4 FY2025+7.00%
Report Date
Nov 14, 2025
EPS Beat/Miss
+60.0%
Price Before
$4.14
Price After
$4.43
Q3 FY2025-4.09%
Report Date
Aug 14, 2025
EPS Beat/Miss
+59.5%
Price Before
$11.26
Price After
$10.80
Q2 FY2025-3.29%
Report Date
May 12, 2025
EPS Beat/Miss
+68.3%
Price Before
$14.27
Price After
$13.80
Q2 FY2025-7.40%
Report Date
Apr 7, 2025
EPS Beat/Miss
-40.2%
Price Before
$16.75
Price After
$15.51
Q4 FY2024-23.44%
Report Date
Nov 13, 2024
EPS Beat/Miss
-8.8%
Price Before
$104.50
Price After
$80.00
Q3 FY2024+0.00%
Report Date
Aug 9, 2024
EPS Beat/Miss
-30.4%
Price Before
$71.00
Price After
$71.00
Avg Beat Reaction-0.78%
Avg Miss Reaction-10.28%
Beat Rate4 / 8 quarters
Largest Move-23.44% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GNPX ends December
Genprex, Inc. (GNPX) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.64 (in line with the analyst consensus of —). GNPX has beaten EPS estimates for 4 consecutive quarters. The next GNPX earnings date is expected around September 1, 2026.
Each quarter, investors track GNPX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GNPX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GNPX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GNPX earnings · 4 questionsGenprex, Inc.'s next earnings report is expected around September 1, 2026. GNPX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GNPX historically reports after market close (AMC).
GNPX earnings datewhen is GNPX earningsGNPX next earnings datewhen does GNPX report earningsGNPX earnings calendar
▸ Source: FMP · Genprex, Inc. SEC filings · US GAAP · Genprex, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026